SCHEMBL8285291

SCHEMBL8285291

CCCC(=O)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40
GABRA3 P34903 2/20 0.40
GABRA2 P47869 2/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
GABRE P78334 1/20 0.40
GABRA6 Q16445 1/20 0.40
GABRG1 Q8N1C3 1/20 0.40
GABRG3 Q99928 1/20 0.40
GABRQ Q9UN88 1/20 0.40
CSF1R P07333 1/20 0.36
GSK3B P49841 4/20 0.36
HPGD P15428 3/20 0.36
MAPT P10636 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287920 0.93 CSF1R (0.37) CSF1RGSK3BHPGDMAPTKDM4E
SCHEMBL8287523 0.88 GSK3B (0.37) CSF1RGSK3BHPGDMAPTALDH1A1
SCHEMBL8286468 0.87 GSK3B (0.38) CSF1RGSK3BHPGDMAPTALDH1A1
SCHEMBL8287593 0.87 GSK3B (0.37) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL8287205 0.86 GSK3B (0.37) CSF1RGSK3BEGFRBTKCDK4
SCHEMBL8287486 0.86 LMNA (0.37) CSF1RGSK3BHPGDMAPTALDH1A1
SCHEMBL8287930 0.86 CSF1R (0.47) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL8362924 0.84 GSK3B (0.39) CSF1RGSK3BHPGDMAPTALDH1A1
SCHEMBL8286472 0.84 EGFR (0.46) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL8287526 0.84 MAPK13 (0.38) GSK3BMAPTKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed